Grace E. Sneary, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1302 Minnich Rd, New Haven, IN 46774 Phone: 260-458-3200 Fax: 260-458-3205 |
Andrea Boley, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1331 Minnich Rd, New Haven, IN 46774 Phone: 260-425-5000 Fax: 260-425-5048 |
Allison Laine Daniels, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1302 Minnich Rd, New Haven, IN 46774 Phone: 260-458-3200 Fax: 260-458-3205 |
Leah Brincefield-wermer, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1331 Minnich Rd, New Haven, IN 46774 Phone: 260-425-5000 Fax: 260-425-5048 |
Amy L Hurst, N.P. Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 108 Landin Rd, New Haven, IN 46774 Phone: 260-493-6565 |
Mrs. Barbara L Rondot, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1302 Minnich Rd, Ste. 4, New Haven, IN 46774 Phone: 260-425-2614 Fax: 260-425-2616 |
News Archive
Complete Genomics, a third-generation human genome sequencing company, today announced publication of a report in the journal Science describing its proprietary DNA sequencing platform, including analysis of sequence data from three complete human genomes. The consumables cost for these three genomes sequenced on the proof-of-principle genomic DNA nanoarrays ranged from $8,005 for 87x coverage to $1,726 for 45x coverage for the samples described in this report.
"Democrats in Washington are navigating treacherous electoral terrain as they craft healthcare reform legislation, judging by new polls that show Americans pulled by conflicting desires on healthcare," according to the CSM.
Ipsen today announced top line results of GuidAge®, the longest (5 years) and largest (2,854 subjects) European study in the prevention of Alzheimer's Dementia (AD). This trial was conducted according to the most stringent international standards. The aim of this study was to assess the efficacy of a 5-year treatment with EGb 761® in the prevention of Alzheimer's Dementia in a population of elderly aged 70 or more, with memory complaint spontaneously expressed to their family physician and who lived at home at the inclusion in the study.
Experts from PAREXEL International Corporation, a leading global biopharmaceutical services provider, will address key trends in late phase development and Comparative Effectiveness Research at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 12th Annual European Congress, to be held from October 24 - 27, 2009 in Paris, France.
Iconix Brand Group, Inc., today announced that it has signed a definitive agreement with United Features Syndicate, Inc. and The E.W. Scripps Company to acquire the Peanuts brand and related assets in partnership with the Schulz family.
› Verified 4 days ago